Department of Neurology (Neurocritical Care), University of Massachusetts Medical School, 55 Lake Ave North, S-5, Worcester, MA, 01655, USA.
Curr Treat Options Neurol. 2014 Jan;16(1):278. doi: 10.1007/s11940-013-0278-x.
Cerebral vasospasm (cVSP) consists of the vasoconstriction of large and small intracranial vessels which can lead to cerebral hypoperfusion, and in extreme cases, delayed ischemic deficits with stroke. While most commonly observed after aneurysmal subarachnoid hemorrhage (aSAH), cVSP can also occur after traumatic brain injury (TBI) as we have described in detail in this review. For the past decades, the research attention has focused on cVSP because of its association with delayed cerebral ischemia, which is the largest contributor of morbidity and mortality after aSAH. New discoveries in the cVSP pathophysiology involving multifactorial complex cascades and pathways pose new targets for therapeutic interventions in the prevention and treatment of cVSP. The goal of this review is to demonstrate the commonalities and differences in epidemiology and pathophysiology of both aSAH and TBI-associated cVSP, and highlight the more recently discovered pathways of cVSP. Finally, the latest cVSP surveillance methods and treatment options are illustrated.
脑血管痉挛(cVSP)是指颅内大、小血管的收缩,可导致脑灌注不足,在极端情况下可导致迟发性缺血性损伤,进而引发卒中。虽然 cVSP 最常见于蛛网膜下腔出血(aSAH)后,但也可发生于创伤性脑损伤(TBI)后,我们在本篇综述中详细描述了这一点。在过去的几十年中,由于其与迟发性脑缺血的关联,cVSP 一直是研究的重点,迟发性脑缺血是 aSAH 后发病率和死亡率的最大原因。cVSP 病理生理学中的新发现涉及多因素复杂级联和途径,为 cVSP 的预防和治疗提供了新的治疗靶点。本篇综述的目的是展示 aSAH 和 TBI 相关 cVSP 在流行病学和病理生理学方面的异同,并强调最近发现的 cVSP 途径。最后,还说明了最新的 cVSP 监测方法和治疗选择。